Literature DB >> 3496131

Proteolytic degradation of von Willebrand factor after DDAVP administration in normal individuals.

J Batlle, M F Lopez-Fernandez, A Lopez-Borrasca, C Lopez-Berges, J A Dent, S D Berkowitz, Z M Ruggeri, T S Zimmerman.   

Abstract

The infusion of 1-deamino-8-D-arginine vasopressin (DDAVP) in normal individuals is followed by an increase in factor VIII/von Willebrand factor (vWF) in plasma, by an increase in intensity of all sizes of multimers, and by the appearance of larger multimers of vWF than those seen in the resting state. Since the larger multimers are rapidly cleared and proteolysis is known to cause disaggregation of large multimers, we evaluated the degree of vWF proteolysis after DDAVP administration. DDAVP was infused into eight normal adult volunteers, and the relative proportions of the intact 225 kilodalton (kDa) subunit and the 189, 176, and 140 kDa vWF fragments were compared before and at different times after DDAVP infusion. The relative proportion of the 176 kDa fragment was increased, whereas that of the other species was decreased, thereby indicating that proteolytic fragmentation had occurred. However, plasmin did not appear to be responsible because the vWF fragments characteristically produced by this enzyme could not be detected. Concomitant analysis of vWF multimeric structure showed that these changes were accompanied by an increase in the relative proportion of the satellite bands, which suggests that they were proteolytically generated. Proteolysis may explain, at least in part, rapid clearance of larger vWF multimers released by DDAVP.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3496131

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  6 in total

Review 1.  von Willebrand factor, Jedi knight of the bloodstream.

Authors:  Timothy A Springer
Journal:  Blood       Date:  2014-06-13       Impact factor: 22.113

Review 2.  Biology and physics of von Willebrand factor concatamers.

Authors:  T A Springer
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

3.  Autosomal dominant C1149R von Willebrand disease: phenotypic findings and their implications.

Authors:  Almudena Pérez-Rodríguez; Aranzazu García-Rivero; Esther Lourés; Maria Fernanda López-Fernández; Angela Rodríguez-Trillo; Javier Batlle
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

4.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

5.  Structural specializations of A2, a force-sensing domain in the ultralarge vascular protein von Willebrand factor.

Authors:  Qing Zhang; Yan-Feng Zhou; Cheng-Zhong Zhang; Xiaohui Zhang; Chafen Lu; Timothy A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-21       Impact factor: 11.205

6.  Platelet-VWF complexes are preferred substrates of ADAMTS13 under fluid shear stress.

Authors:  Kyuhwan Shim; Patricia J Anderson; Elodee A Tuley; Erin Wiswall; J Evan Sadler
Journal:  Blood       Date:  2007-09-27       Impact factor: 22.113

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.